TAK — Takeda Pharmaceutical Share News
0.000.00%
Last trade - 00:00- $66.14bn
- $92.15bn
- ¥5tn
Pharvaris' genetic disorder drug meets main goal in late-stage trial (updated)
Trump administration to announce drug pricing deals
US FDA approves Takeda, Protagonist's drug for rare blood cancer (updated)
US FDA approves Takeda, Protagonist's drug for rare blood cancer
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Silence Therapeutics jumps after mid-stage trial data for blood cancer drug
US FDA approves Takeda's sleep disorder pill (updated)
US FDA approves Takeda's sleep disorder pill
Takeda Pharmaceutical Co Ltd reports results for the quarter ended June 30 - Earnings Summary
Table: Takeda Pharma -Q1 group results (IFRS)
China's Innocare says psoriasis oral drug shows 'consistent treatment effect' in late-stage trial (updated)
AI shortens drug discovery to around 1 year in China, Insilico CEO says
Japanese drugmaker Takeda's Qdenga becomes first dengue vaccine approved in India (updated)
Takeda's QDENGA becomes first dengue vaccine approved in India
Brief: Takeda Pharmaceutical's Qdenga (Tak-003) Becomes First Dengue Vaccine To Be Approved In India- Statement
Taiwan's Bora Pharmaceuticals in potential $2.5 billion collaboration with Insilico Medicine (updated)
Takeda And Indonesian Government Announce Landmark Collaboration To Strengthen Healthcare Resilience And Expand Access To Lifesaving Plasma-Derived Medicinal Products
Press Digest: Wall Street Journal - July 2
Brief: Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up To $600 Million - WSJ